Technical Description
The present invention relates to an amide linkage-based heterocyclic derivative as a choline acetyltransferase inhibitor for early-stage detection of Alzheimer’s disease..
Problems Addressed
- Expensive
- Limited Diagnostic Capability
- Low Inhibition Efficiency
- Delayed Alzheimer Detection
Tech Features
- Cost-Effective
- Proactive Detection
- Novel Compound Design
- ChAT inhibitor
- Target-Specific Detection
- Versatile Structural Motifs
Target Audience
- Healthcare and Diagnostics Sector
- Pharmaceutical Industry
- Biotechnology Industry
- Research & Development
Tech ID: P27-1417 TRL 4 Patent Status: Granted Available For Exclusive and Non-exclusive License
